Periodically I will add posts here if the sources provide additioanl informaiton on how to think about and deal with Dementia/ Alzheimer's Disease.


SCROLL DOWN FOR TEXT and BIBLIOGRAPHY from DAI WEBINAR 2/22-23/2017. You can also find this information on my website:

Even though this blog is now dormant (see info below) there are many useful, insightful posts. Scroll back from the end or forward from the beginning. My guess is that you could spend a lot of time here and maybe learn or experience a thing or two about living with and loving someone with Dementia/Alzheimer's or maybe come away with the feeling that "you are not alone" in YOUR work with the same!

• • • • •


Happy New Year 2016. With a new year comes new beginnings and sometimes endings. If I am personally progressing and if I am doing a good job in my grieving Gregory's death; if I have been able to learn my lessons in living and loving someone diagnosed with Dementia/ Alzheimer's; if I am to get on with my life ... I need to bring this Alzheimer's blog to an end since my writing has been dealing less with Dementia/ Alzheimer's and more with life after Dementia/ Alzheimer's.

Of course, I will always continue to work for and support fair treatment on behalf of people with Dementia/ Alzheimer's and may post here from time to time. Also, there are many wonderful posts here through which you may browse.

With this change, I will continue and reinvigorate my "michael a. horvich writes" blog which deals with grieving Gregory's death, life lessons, personal experiences, observations, memoirs, dreams, and humor in essay and poetry, as well as an attempt now and then at sharing a piece of fiction.

Please follow me there by clicking or click the link located on the right side of this page.

Finally, COMMENTS are always important to me and you can still comment on the posts on this blog! CLICK "Comments" and sign in or use "Anonymous." Leave your name or initials if you wish so I'll know it's you? Check the "Notify Me" box to see my reply to you.

Monday, August 10, 2015

Possible Good News

This article originally appeared on VICE UK.
A new drug that could reduce the effect of Alzheimer's disease by 30 percent has just been revealed at today's Alzheimer's Association International Conference in Washington, DC.
One thousand patients were given an infusion of an antibody called solanezumab once a month, over a period of one-and-a-half years, and the study has shown that the antibody significantly reduces the decline in brain function of patients in the early stages of the disease. As Dr. Eric Siemers from the Lilly Research Laboratories, in Indiana, told the BBC, "It's another piece of evidence that solanezumab does have an effect on the underlying disease pathology."
It's not a cure, but this does come as something of a breakthrough, since older Alzheimer drugs only tackle the symptoms. Now, the new drug should reduce the rate at which the disease takes over a person, meaning more people who suffer from the disease could potentially live longer.
An earlier 18-month trial of solanezumab ended in failure in 2012, but this one serves as a landmark moment—as a representative the Alzheimer's Research branch in the UK put it, if this gets replicated, then it's "a real breakthrough in Alzheimer's research."
In the UK, some 850,000 people suffer from the disease, with this number expected to rise to 1 million by 2025. Of America's top ten causes of death, Alzheimer's is the only disease that cannot be prevented, cured, or slowed. Every 67 seconds, someone in the US develops the disease. Solanezumab looks like it could at least prolong a sufferer's life span. A new trial on the antibody, to begin next year, should tell us for sure.

No comments:

Post a Comment

Comments are always welcome. You are appreciated! If you do not have a sign-in on any of the accounts below ... use ANONYMOUS. All comments are moderated and will appear as appropriate. Thanks. Please, keep commenting!